Quality of life of patients with locally advanced head and neck cancer treated with induction chemotherapy followed by cisplatin-containing chemoradiotherapy in the Dutch CONDOR study: a randomized controlled trial

被引：0
|
作者：
Chantal M. L. Driessen
Johannes M. M. Groenewoud
Jan Paul de Boer
Hans Gelderblom
Winette T. A. van der Graaf
Judith B. Prins
Johannes H. A. M. Kaanders
Carla M. L. van Herpen
机构：
[1] Radboud University Medical Center,Department of Medical Oncology
[2] Radboud University Medical Center,Department of Health Evidence
[3] Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital,Department of Medical Oncology
[4] Leiden University Medical Centre,Department of Medical Oncology
[5] The institute of Cancer Research and the Royal Marsden NHS Foundation Trust,Department of Medical Psychology
[6] Radboud University Medical Center,Department of Radiation Oncology
[7] Radboud University Medical Center,undefined
来源：
Supportive Care in Cancer | 2018年 / 26卷
关键词：
Quality of life; Symptoms; Locally advanced head and neck cancer; Induction chemotherapy; Chemoradiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1233 / 1242
页数：9
相关论文
共 50 条
  • [1] Quality of life of patients with locally advanced head and neck cancer treated with induction chemotherapy followed by cisplatin-containing chemoradiotherapy in the Dutch CONDOR study: a randomized controlled trial
    Driessen, Chantal M. L.
    Groenewoud, Johannes M. M.
    de Boer, Jan Paul
    Gelderblom, Hans
    van der Graaf, Winette T. A.
    Prins, Judith B.
    Kaanders, Johannes H. A. M.
    van Herpen, Carla M. L.
    SUPPORTIVE CARE IN CANCER, 2018, 26 (04) : 1233 - 1242
  • [2] Induction chemotherapy (IC) with docetaxel/cisplatin/5-fluorouracil (TPF) followed by cisplatin-containing concomitant chemoradiotherapy (CRT) in fit patients with locally advanced head and neck cancer (LAHNC): The CONDOR study-A study of the Dutch Head and Neck Society
    Driessen, Chantal
    De Boer, J. P.
    Gelderblom, Hans
    Rasch, Coen R. N.
    de Jong, Martin
    Verbist, Berit M.
    Tesselaar, Margot Et
    Van der Graaf, Winette T. A.
    Kaanders, J. H.
    Van Herpen, Carla M. L. -
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Quality of life of patients with locally advanced head and neck cancer (LAHNC) treated with docetaxel/cisplatin/5-fluorouracil (TPF) followed by cisplatin-containing chemoradiotherapy (CRT).
    Driessen, Chantal
    Groenewoud, Hans
    De Boer, J. P.
    Gelderblom, Hans
    Tesselaar, Margot Et
    Van der Graaf, Winette T. A.
    Kaanders, J. H.
    L-Van Herpen, Carla M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Efficacy and toxicity of docetaxel/cisplatin/5-fluorouracil (TPF) induction chemotherapy followed by two schedules cisplatin-containing concomitant chemoradiotherapy (CRT) in patients with locally advanced head and neck cancer (LAHNC): The CONDOR study
    Driessen, C. M. L.
    De Boer, J. P.
    Gelderblom, H.
    Rasch, C. R. N.
    De Jong, M. A.
    Verbist, B. M.
    Tesselaar, M. E. T.
    Van der Graaf, W. T. A.
    Kaanders, J. H. A. M.
    Van Herpen, C. M. L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S749 - S749
  • [5] CISPLATIN-CONTAINING CHEMOTHERAPY IN ADVANCED HEAD AND NECK-CANCER
    PATERSON, ICM
    QUILTY, PM
    CLINICAL RADIOLOGY, 1985, 36 (06) : 607 - 610
  • [6] Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study)
    Driessen, Chantal M.
    Ham, Janneke C.
    te Loo, Maroeska
    van Meerten, Esther
    van Lamoen, Maurits
    Hakobjan, Marina H.
    Takes, Robert P.
    van der Graaf, Winette T.
    Kaanders, Johannes H.
    Coenen, Marieke J. H.
    van Herpen, Carla M.
    CANCERS, 2019, 11 (04)
  • [7] Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study
    Driessen, C. M. L.
    de Boer, J. P.
    Gelderblom, H.
    Rasch, C. R. N.
    de Jong, M. A.
    Verbist, B. M.
    Melchers, W. J. G.
    Tesselaar, M. E. T.
    van der Graaf, W. T. A.
    Kaanders, J. H. A. M.
    van Herpen, C. M. L.
    EUROPEAN JOURNAL OF CANCER, 2016, 52 : 77 - 84
  • [8] Taxane-containing induction chemotherapy followed by definitive chemoradiotherapy Outcome in patients with locally advanced head and neck cancer
    Broemme, J. O.
    Schmuecking, M.
    Arnold, A.
    Giger, R.
    Rauch, D.
    Leiser, D.
    Plasswilm, L.
    Geretschlaeger, A.
    Ghadjar, P.
    Aebersold, D. M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (08) : 618 - 624
  • [9] Comparative study of induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone in locally advanced head and neck cancer
    Dhaka, Saroj
    Jakhar, Shankar Lal
    Sharma, Neeti
    Kumar, Harvinder Singh
    Kumar, Rajesh
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (09) : S146 - S150
  • [10] Ototoxicity in locally advanced head and neck cancer patients treated with induction chemotherapy followed by intermediate or high-dose cisplatin-based chemoradiotherapy
    Driessen, Chantal M. L.
    Leijendeckers, Joop
    Snik, Ad
    van der Graaf, Winette T. A.
    de Boer, Jan Paiul
    Gelderblom, Hans
    Kaanders, Johannes H. A. M.
    Takes, Robert
    van Herpen, Carla M. L.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (02): : 488 - 494
12345